AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0123
+0.0020 (18.93%)
Apr 25, 2024, 3:59 PM EDT - Market closed
AXIM Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.04 | 0.01 | 0.06 | 0 | 0.8 | 0.2 | 0.05 | 0.05 | 0.05 | 0 | Upgrade
|
| Revenue Growth (YoY) | 345.27% | -85.32% | - | - | 308.70% | 311.19% | 1.09% | -4.23% | - | - | Upgrade
|
| Cost of Revenue | 0.43 | 0.43 | 0 | 0.02 | 0.58 | 0.01 | 0.04 | 0.15 | 0.05 | 0 | Upgrade
|
| Gross Profit | -0.39 | -0.42 | 0.06 | -0.02 | 0.22 | 0.19 | 0 | -0.11 | -0 | 0 | Upgrade
|
| Selling, General & Admin | 2.24 | 4.08 | 5.67 | 4.51 | 4.27 | 3.16 | 1.8 | 3.41 | 9.48 | 0 | Upgrade
|
| Research & Development | 0.13 | 0.15 | 0.28 | 0.43 | 2.45 | 2.06 | 1.35 | 0.24 | 0.57 | 0 | Upgrade
|
| Other Operating Expenses | -0.08 | 0.43 | 1.84 | -0.1 | 0 | 0 | 0 | 0 | 0 | 0.51 | Upgrade
|
| Operating Expenses | 2.36 | 4.66 | 7.79 | 4.83 | 6.73 | 5.22 | 3.15 | 3.65 | 10.05 | 0.51 | Upgrade
|
| Operating Income | -2.75 | -4.65 | -7.99 | -4.95 | -6.51 | -5.04 | -3.15 | -3.76 | -10.05 | -0.51 | Upgrade
|
| Interest Income | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 1.2 | 1.88 | 0.49 | 0.32 | 0.32 | 1.58 | 1.02 | 0.3 | 0.04 | 0.03 | Upgrade
|
| Other Expense / Income | 4.1 | -0.29 | 7.55 | 1.02 | -0.08 | -1.3 | -0.32 | 0.27 | - | - | Upgrade
|
| Pretax Income | -8.06 | -6.24 | -16.02 | -6.29 | -6.45 | -6.75 | -4.17 | -5.81 | -10.09 | -0.54 | Upgrade
|
| Income Tax | 0 | -0.29 | 0.49 | 0.44 | 0.32 | 1.44 | 0.32 | 1.48 | 0 | 0.04 | Upgrade
|
| Net Income | -8.06 | -5.96 | -16.52 | -6.73 | -6.77 | -6.75 | -4.17 | -5.81 | -10.09 | -0.58 | Upgrade
|
| Shares Outstanding (Basic) | 228 | 165 | 132 | 110 | 62 | 57 | 53 | 42 | 37 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | 228 | 165 | 132 | 110 | 62 | 57 | 53 | 42 | 37 | 33 | Upgrade
|
| Shares Change | 37.60% | 25.79% | 19.16% | 78.19% | 8.14% | 7.48% | 27.71% | 12.62% | 12.29% | - | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.13 | -0.06 | -0.11 | -0.12 | -0.08 | -0.14 | -0.27 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.13 | -0.06 | -0.11 | -0.12 | -0.08 | -0.14 | -0.27 | -0.02 | Upgrade
|
| Free Cash Flow | -1.03 | -2.05 | -2.54 | -3.31 | -5.02 | -4.85 | -3.08 | -1.29 | -1.56 | -0.34 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.03 | -0.08 | -0.08 | -0.06 | -0.03 | -0.04 | -0.01 | Upgrade
|
| Gross Margin | -980.57% | -4701.42% | 100.00% | - | 27.99% | 95.65% | 9.91% | -227.53% | -2.54% | - | Upgrade
|
| Operating Margin | -6960.98% | -52425.60% | -13207.09% | - | -813.73% | -2574.53% | -6619.48% | -7988.83% | -20451.26% | - | Upgrade
|
| Profit Margin | -20394.96% | -67120.74% | -27320.76% | - | -846.98% | -3453.05% | -8761.70% | -12346.00% | -20539.22% | - | Upgrade
|
| Free Cash Flow Margin | -2607.67% | -23132.80% | -4196.59% | - | -627.92% | -2476.95% | -6478.37% | -2750.04% | -3166.44% | - | Upgrade
|
| EBITDA | -2.32 | -4.23 | -5.87 | -4.82 | -6.5 | -5.02 | -3.14 | -3.76 | -10.05 | -0.51 | Upgrade
|
| EBITDA Margin | -5880.41% | -47621.28% | -9707.77% | - | -812.92% | -2567.97% | -6609.07% | -7981.70% | -20448.98% | - | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.43 | 2.12 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| EBIT | -2.75 | -4.65 | -7.99 | -4.83 | -6.51 | -5.04 | -3.15 | -3.76 | -10.05 | - | Upgrade
|
| EBIT Margin | -6960.98% | -52422.70% | -13207.09% | - | -813.73% | -2574.53% | -6616.13% | -7988.83% | -20451.26% | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.